Pfizer 2Q mixed, maintains 2013 outlook

Home › Pfizer 2Q mixed, maintains 2013 outlook

The drug company earned $14.1 billion, or $1.98 per share. That compares with $3.25 billion, or 43 cents per share, a year earlier.

03.07	Greece starts six-day working week for some industries
03.07	ThaMa-Vet unveils fixed dosage swine syringes
03.07	Hurricane Beryl Graphics
03.07	Farm Progress America, July 3, 2024
03.07	Farm Progress America, July 3, 2024
03.07	Digital video subscriptions to reach 3.5 billion by 2028
03.07	Hurricane Beryl Forecast Discussion Number 19
03.07	Hurricane Beryl Wind Speed Probabilities Number 19
More »

je.st